COMMUNIQUÉS West-GlobeNewswire

Viveve Announces Settlement of Patent Infringement Litigation with Thermi

04/06/2018 - 14:28

ENGLEWOOD, Colo., June 04, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that is has reached a settlement to resolve the [...]

Evolus to Present at the Jefferies 2018 Global Healthcare Conference

04/06/2018 - 14:01

IRVINE, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (“Evolus”) (NASDAQ:EOLS), a premiere aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, [...]

Results from Phase 1 Study of CB-839 in Combination with Capecitabine in Advanced Solid Tumors to be Presented at the 2018 American Society of Clinical Oncology (ASCO)

04/06/2018 - 14:01

Phase 2 to Continue Enrolling Colorectal Cancer Patients with PIK3CA Mutation SOUTH SAN FRANCISCO, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology [...]

DBV Technologies : Correctif - Assemblée Générale Mixte du 22 juin 2018 - Modalités de mise à disposition des documents préparatoires à l'Assemblée

04/06/2018 - 14:00

Montrouge, France, le 1 juin (07h30 CEST) 2018 Assemblée Générale Mixte du 22 juin 2018 Modalités de mise à disposition des documents préparatoires à l'Assemblée DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - [...]

Athenex Names Christina Wang as Vice President of Clinical Operations and Corporate Development, Asia Pacific

04/06/2018 - 14:00

BUFFALO, N.Y., June 04, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Versartis Enters into Merger Agreement with Aravive Biologics to Form a Clinical-Stage Biopharmaceutical Company Advancing Innovative Oncology Therapeutics

04/06/2018 - 14:00

- Tolerability and proof-of-mechanism for lead candidate AVB-S6-500, a novel GAS6-AXL pathway inhibitor, established in ongoing Phase 1 clinical study - Multi-study clinical development program in combination with [...]

Checkpoint Therapeutics to Participate in June Investor Conferences

04/06/2018 - 14:00

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

Soleno Therapeutics To Present Corporate Update at the BIO International Convention

04/06/2018 - 14:00

REDWOOD CITY, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Retrophin Announces Pivotal Phase 3 FORT Study of Fosmetpantotenate in PKAN Opens Enrollment to Pediatric Patients

04/06/2018 - 14:00

Independent Data Monitoring Committee’s (DMC) review of available safety data supports continuing with study as planned; FORT Study now open to pediatric patients aged 6 to 17 Top-line data anticipated in the second [...]

Daré Bioscience, Inc. Expands Leadership Team, Appointing Mary Jarosz, RPh, to Global Head of Regulatory Affairs

04/06/2018 - 14:00

SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of Mary Jarosz, RPh, to the newly created role of [...]

Cocrystal Pharma Announces Nasdaq Closing Bell Ceremony

04/06/2018 - 14:00

ATLANTA, GA and BOTHELL, WA, June 04, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]

Novo Nordisk A/S - Share repurchase programme

04/06/2018 - 13:16

Bagsværd, Denmark, 4 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]

Aptose Announces Two Publications of Preclinical Data Elucidating the Anticancer Mechanism of Action of APTO-253

04/06/2018 - 13:04

Identification of APTO-253 target leading to inhibition of MYC expression in AML and hypersensitivity of cancer cells with BRCA1/2 deficiencies SAN DIEGO and TORONTO, June 04, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences [...]

Avalon GloboCare Appoints Former Deputy Secretary of the U.S. Department of Health and Human Services Dr. Tevi Troy to its Board of Directors

04/06/2018 - 13:00

FREEHOLD, N.J, June 04, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed Dr. Tevi Troy, Former Deputy [...]

NexoBrid® Receives Marketing Authorization From South Korea’s Ministry of Health

04/06/2018 - 13:00

Exclusive distributor BL&H Co., Ltd. plans commercial launch in second half of 2018 YAVNE, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company [...]

Assembly Biosciences to Participate in Jefferies 2018 Global Healthcare Conference

04/06/2018 - 13:00

INDIANAPOLIS and SAN FRANCISCO, June 04, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]

Results of Kamada’s Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Association’s 78th Scientific Sessions

04/06/2018 - 13:00

REHOVOT, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the results from the Company’s Phase 2 trial of Alpha-1 [...]

AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide

04/06/2018 - 13:00

WALTHAM, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for bremelanotide, [...]

Athenex Announces Poster Presentations at ASCO Annual Meeting

04/06/2018 - 13:00

BUFFALO, N.Y., June 04, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]